Drug intelligence / Profile preview

alginic sodium diester

Development stage
Unknown
Lead developer
i-ChinaPharma-Intelligence
Modality
Small Molecules
Administration
Oral, Intravenous
01

Overview

Alginic sodium diester, also known as propylene glycol alginate sodium sulfate (PSS), is a semi-synthetic sulfated polysaccharide derivative extracted from alginic acid through chemical modification. It possesses a variety of pharmacological actions, most notably anticoagulant and antithrombotic effects, with an anticoagulant potency approximately one-third to one-half that of heparin. The drug also exhibits antiplatelet aggregation, lipid-lowering, and vasodilatory properties, which collectively work to reduce blood viscosity and improve microcirculation. It is primarily indicated for the prevention and treatment of ischemic cardiovascular and cerebrovascular diseases, including cerebral thrombosis, coronary heart disease, and stroke, as well as hyperlipidemia and hyperviscosity syndrome. Additionally, it has been utilized in the management of disseminated intravascular coagulation (DIC) and chronic glomerulonephritis.

Brand names
Taizhiao
Other names
propylene glycol alginate sodium sulfatepolysaccharide sulfatesodium alginate diester
02

Targets

ATIII (Antithrombin III)

Beyond the preview

Go deeper on alginic sodium diester.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on alginic sodium diester.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call